Kathryn H. Schmitz | |
---|---|
Relatives | John Haltiwanger (brother) Robert S. Haltiwanger (brother) |
Academic background | |
Education | BA, Economics, 1984, University of North Carolina MSEd, Exercise Physiology, Queens College, City University of New York PhD, 1998, MPH, 1999, University of Minnesota |
Academic work | |
Institutions | Perelman School of Medicine at the University of Pennsylvania Penn State University College of Medicine University of Minnesota |
Mary Kathryn "Katie" Haltiwanger Schmitz is an American exercise physiologist. She is the Associate Director of Population Sciences at Penn State University College of Medicine and a Full Professor at the Perelman School of Medicine at the University of Pennsylvania.
Growing up in New York,Schmitz was a dancer with the Martha Graham Dance Ensemble and a personal trainer and manager of the Salomon Brothers executive fitness center. While working at the fitness center,Schmitz realized she was often unable to answer clients questions due to a lack of knowledge. [1] As a result,Schmitz decided to earn a master's degree in exercise science from Queens College,City University of New York and an MPH and doctorate in exercise physiology from the University of Minnesota. [2]
Upon receiving her PhD,Schmitz joined the University of Minnesota's School of Public Health faculty before accepting a position at the University of Pennsylvania (UPenn). She later recalled that she chose to switch institutions because of UPenn's "strong exercise physiology program." [3] While at the University of Minnesota,Schmitz conducted a small scale study on women with or without lymphedema and strength training. The results found that lymphedema symptoms go better in women who did strength training,as well as improved their strength,body fat percentage,and their quality of life. [4] As an assistant professor of epidemiology at the Penn State University College of Medicine,Schmitz's research focused on understanding the connection between physical activity and diseases. In 2006,she launched a study on the effectiveness of YMCA memberships combined with supervised strength training classes on overweight and obese women. [5] Her research began to gain more attraction when she published her randomized trial of weight lifting for breast cancer survivors. [6]
As an associate professor in the department of biostatistics and epidemiology,Schmitz established the SHE study (for Strong,Healthy and Empowered),to prove that resistance exercise significantly slowed middle-age weight gain. [1] By June,she was appointed the lead author of the first American College of Sports Medicine Roundtable on Exercise for Cancer Survivors,which published guidance for exercise testing and prescription for cancer survivors. [2] Formally,upper body exercises were discouraged for survivors,but Schmitz's research suggested that patients avoid inactivity both during and after cancer treatment. [6] She later co-published a randomized trial study which was aimed at determining the benefits breast cancer survivors without lymphedema could enjoy through weightlifting. Her research team compared the results one year of weight lifting intervention could have on survivors at risk for breast cancer–related lymphedema. [7] Her research was recognized by the National Lymphedema Network with the awarding of the Catalyst Award for "being a researcher whose work has stimulated thought,discussion,and debate that leads to improvement in patient care for those with lymphedema." [8]
In 2011,the National Cancer Institute granted the Perelman School of Medicine a $10 million grant to establish a new center focusing on the relationship between exercise,weight loss,and improving the length and quality of life. Schmitz was appointed the leader of one trial in the center which focused on examining the relationship between lymphedema and weight loss in overweight breast cancer survivors. [9] She later transferred her Transdisciplinary Research on Energetics and Cancer (TREC) Center grant to the Penn State Cancer Institute and became the associate director of population sciences. [10] In 2017,Schmitz became the president-elect of the American College of Sports Medicine [11] and was nominated for UPenn's Innovator of the Year Award. [12] In her role as associate director,Schmitz co-developed updated guidelines and exercise recommendations for people living with cancer or survivors of the disease. [13]
Leonard Abramson is a philanthropist and the founder and former CEO of U.S. Healthcare.
The Perelman School of Medicine is the medical school of the University of Pennsylvania,a private,Ivy League research university located in Philadelphia. Founded in 1765,the Perelman School of Medicine is the oldest medical school in the United States. Today,the Perelman School of Medicine is a major center of biomedical research and education with over 2,900 faculty members and nearly $1 billion in annual sponsored program awards.
David B. Sarwer is an American clinical psychologist who serves as the Associate Dean for Research,Director of the Center for Obesity Research and Education,and Professor of Social and Behavioral Sciences in the College of Public Health at Temple University.
Retinal vasculopathy with cerebral leukocencephalopathyand systemic manifestations is an inherited condition resulting from a frameshift mutation in the C-terminal region of the TREX1 gene.
Carolyn Kaelin was an American cancer surgeon. She worked at the Dana–Farber Cancer Institute and founded the Comprehensive Breast Health Center at Brigham and Women’s Hospital in 1995.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Shiriki K. Kumanyika is an Emeritus Professor of Biostatistics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania and co-chair of the International Association for the Study of Obesity International Obesity Task Force. She has previously served as Associate Dean for Disease Prevention and was founding director of the University of Pennsylvania Master of Public Health. She chairs the African American Collaborative Obesity Research Network. She is the former president of the American Public Health Association.
Susan M. Domchek is an oncologist at the University of Pennsylvania,Executive Director of the Basser Center for BRCA,the Basser Professor in Oncology at the Perelman School of Medicine,and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at Penn Medicine. She has authored more than 250 articles in scholarly journals. In 2018,Domchek was elected to the National Academy of Medicine.
Sara R. Cherry is an American microbiologist who is John W. Eckman Professor of Medical Science and Professor of Microbiology in Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania. Her research involves genetic and mechanistic studies of virus–host interactions. During the COVID-19 pandemic,Cherry looked to identify novel therapeutic strategies.
Nadia Lauren Dowshen is an American pediatrician and adolescent medicine physician. She specializes in the care of youth living with HIV infection and medical care to transgender and gender-diverse youth. Dowshen researches health inequality,access to care,and promoting resilience in LGBT youth. As an associate professor at the Perelman School of Medicine at the University of Pennsylvania,she is also the medical director and co-founder of the Gender and Sexuality Development Clinic.
Karen Glanz is an American behavioral epidemiologist. She is the George A. Weiss University Professor at the University of Pennsylvania. Glanz is a member of the National Academy of Medicine and has been recognized as one of the world's most influential scientific minds.
Janet Alma Deatrick is a Professor Emerita at the University of Pennsylvania's School of Nursing.
Maryam Beheshti Lustberg is an American breast oncologist. She is the Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. Lustberg previously served as the Medical Director of Supportive Care at Ohio State's Comprehensive Cancer Center and President of the Multinational Association of Supportive Care in Cancer. She is also an associate editor for the peer-reviewed medical journal covering oncology nursing with respect to cancer survivors called Journal of Cancer Survivorship. Lustberg was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.
Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007,she was elected to the Institute of Medicine.
Katrina Alison Armstrong is an American internist,and the interim president of Columbia University since August 2024. She is also CEO of Irving Medical Center and dean of the Faculties of Health Sciences at the university.
Raina Martha Merchant is an American emergency medicine specialist,a member of the National Academy of Medicine. She is the associate vice president and director of the Center for Digital Health in Penn Medicine and associate professor of emergency medicine in the Perelman School of Medicine at the University of Pennsylvania.
Rinad S. Beidas is an American clinical child psychologist and implementation scientist. She is currently the chair and Ralph Seal Paffenbarger Professor of the department of Medical Social Sciences at the Northwestern University Feinberg School of Medicine. She was formerly professor of Psychiatry and Medical Ethics and Health Policy at the Perelman School of Medicine at the University of Pennsylvania;Founding Director of the Penn Implementation Science Center (PISCE@LDI);and Director of the Penn Medicine Nudge Unit. She also served as Associate Director at the University of Pennsylvania's Center for Health Incentives and Behavioral Economics (CHIBE).
Erika L F. Holzbaur is an American biologist who is the William Maul Measey Professor of Physiology at University of Pennsylvania Perelman School of Medicine. Her research considers the dynamics of organelle motility along cytoskeleton of cells. She is particularly interested in the molecular mechanisms that underpin neurodegenerative diseases.
Marion Leary is the Director of Innovation at the University of Pennsylvania School of Nursing and an American resuscitation science researcher.